Follow
Stephen Checkley
Title
Cited by
Cited by
Year
Bridging the gap between in vitro and in vivo: dose and schedule predictions for the ATR inhibitor AZD6738
S Checkley, L MacCallum, J Yates, P Jasper, H Luo, J Tolsma, ...
Scientific reports 5 (1), 1-12, 2015
682015
Demonstration of the feasibility of predicting the flow of pharmaceutically relevant powders from particle and bulk physical properties
H Barjat, S Checkley, T Chitu, N Dawson, A Farshchi, A Ferreira, ...
Journal of pharmaceutical innovation 16, 181-196, 2021
242021
Using human in vitro transcriptome analysis to build trustworthy machine learning models for prediction of animal drug toxicity
LJ Gardiner, AP Carrieri, J Wilshaw, S Checkley, EO Pyzer-Knapp, ...
Scientific reports 10 (1), 9522, 2020
182020
Combining human cell line transcriptome analysis and Bayesian inference to build trustworthy machine learning models for prediction of animal toxicity in drug development
LJ Gardiner, AP Carrieri, J Wilshaw, S Checkley, EO Pyzer-Knapp, ...
arXiv preprint arXiv:1911.04374, 2019
2019
Establishment of intestinal free mucus PK-efficacy relationship for gastrointestinal limited drugs
J Zhang, C Bendtsen, S Checkley, B Zhang, P Liu, D Zhang, Z Cheng
Drug Metabolism and Pharmacokinetics 1 (32), S92, 2017
2017
Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738 (vol 5, 13545, 2015)
S Checkley, L MacCallum, J Yates, P Jasper, H Luo, J Tolsma, ...
SCIENTIFIC REPORTS 6, 2016
2016
Engineering tuneable gene circuits in yeast
S Checkley
PQDT-UK & Ireland, 2015
2015
251 A combined in vitro and mathematical modelling approach for understanding the impact of an inhibitor of ATR on DNA damage and repair after ionising radiation
J Yates, S Checkley, L MacCallum, R Odedra, J Barnes, A Lau
European Journal of Cancer, 84, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–8